Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
New UCSF study analyzes prostate cancer deaths by race.
Less than 5 percent of Black patients were involved in trials for 24 out of 31 cancer drugs approved since 2015.
Studies show African-American men may respond better to treatment and survive longer.
Insurance accounts for 37 percent of the total excess risk of death in Black patients, study finds.
At a major transplant center in Indiana, despite similar levels of liver disease severity, Blacks had a lower transplant rate than whites.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.